Recently, we and others reported instability in the (C)8 repeat in exon 5 of MSH6 as a preferential target for somatic mutations in tumours from MSH6 germline mutation carriers. Here, we report that in 45% of tumours from MLH1, MSH2 and MSH6 germline mutation carriers no sequence change in the (C)8 repeat of MSH6 was found upon DNA sequencing analysis of PCR products with a shift in electrophoresis mobility. Using`standard' PCR primers a high frequency of instability (50 ± 86%) of the (C)8 repeat was found, but using a modi®ed PCR reverse primer, accomplishing modulation of non-templated addition of adenine during in vitro PCR ampli®cation by the Taq polymerase, a markedly lower frequency of instability was found in tumours from MLH1, MSH2 and MSH6 mutation carriers (6, 13 and 40%, respectively). Furthermore, a signi®cant dierence of the frequency of instability of the (C)8 repeat in tumours from MSH6 mutation carriers was found compared to MLH1, MSH2 mutation carriers. These results might have important implications for the detection of instability of other short mononucleotide repeats, e.g. TGFbRII, BAX, IGFRII, PTEN, BRCA2. Oncogene (2001) 20, 6241 ± 6244.
Keywords: HNPCC; MSI; MSH6; repeat; microsatellite Correction of mismatched base pairs resulting from replication errors is essential for the maintenance of genetic stability. Mutations in genes encoding human MutS (MSH2, MSH6, MSH3) or MutL (MLH1, PMS1, PMS2) homologues involved in DNA mismatch repair (MMR) will result in genetic instability characterized by a high frequency of alterations in microsatellite repeat sequences (MSI-phenotype) (Peltomaki et al., 1997) . Somatic mutation induced by MMR-driven mutagenesis, predominantly as single base pair deletions or insertions, causes frameshifts and premature chain terminating signals in genes. In previous studies high frequencies of instability of mononucleotide repeats have been found in coding regions of e.g. TGFbRII, BAX, IGFRII, PTEN, BRCA2 and in the MMR genes MSH3 and MSH6 in HNPCC-associated tumours Souza et al., 1996; Rampino et al., 1997; Malkhosyan et al., 1996; Guanti et al., 2000; Koul et al., 1999) . Inactivation of these genes is most likely selected for during MMR-driven tumourigenesis.
We and others recently reported the identi®cation of MSH6 germline mutation in patients from atypical HNPCC families (Akiyama et al., 1997; Miyaki et al., 1997; Kolodner et al., 1999; Wijnen et al., 1999; . Interestingly, MSI analysis of tumours from patients with MSH6 germline mutations, determined by DNA fragment length analysis of microsatellite repeat markers (Boland et al., 1998) , showed a high frequency of instability of predominantly mononucleotide repeats, including the (C)8 repeat in exon 5 (codons 1116 ± 1118) of MSH6. We found instability of the (C)8 repeat of MSH6 in all tumours from four kindreds with truncating germline MSH6 mutations. Immunohistochemical studies of the MMR repair proteins MLH1, MSH2 and MSH6, showed loss of MSH6 staining in tumour cells, indicating biallelic inactivation of MSH6 (De Leeuw et al., 2000) . Together, these data suggest that MSH6 represents a preferential target for somatic inactivation in MSH6 germline mutation carriers. However, systematic validation of the somatic sequence changes in the (C)8 repeat of MSH6 underlying the detection of this high frequency of instability in tumours from MSH6 germline mutation carriers by e.g. DNA sequence analysis of the (C)8 repeat has not been reported. Recently, Fishel et al. (1999) reported that somatic frameshift inactivation of MSH6 by instability of the (C)8 repeat in exon 5 of MSH6 should be interpreted with caution, as PCR artifacts are commonly associated with this sequence.
Random non-templated addition of adenine by the Taq-polymerase during in vitro PCR ampli®cation can Figure 1 Microsatellite analysis and DNA sequence analysis of the (C)8 repeat of MSH6 from MSH6 germline mutation carriers. For analysis of the (C)8 repeat from both constitutive normal DNA (N) and tumour DNA (T) two PCRs were performed, using one standard MSH6-(C)8-forward primer: 5'-GGG TGA TGG TCC TAT GTG TC-3', and two dierent MSH6 reverse primers: standard MSH6-(C)8 reverse primer: 5'-TTT CCT GCT CCT CTT CCT CA-3' (STD), and modi®ed MSH6-(C)8 reverse primer: 5'-GTT TCT TTT TCC TGC TCC TCT TCC TCA-3' (MOD). PCR reaction was performed under conditions recommended by the manufacturer (PE Biosystems Inc., Foster City, USA), containing 5 pmol FAM (normal DNA) or TET (tumour DNA) labelled forward primer and 5 pmol unlabelled reverse primer for 12 min 968C, 33 cycles of 1 min 968C, 2 min 558C, 1 min 728C, delay extension step of 7 min 728C in a GeneAmp 9700 thermocycler (PE Biosystems Inc., Foster City, USA). PCR products were run on cause problems in genotyping using short tandem repeats (STRs) (Magnuson et al., 1996; Smith et al., 1995) . In several studies it has been shown that protection for random non-templated addition of adenine was inecient and mainly primer-sequence dependent. A modi®cation of the reverse PCR primer by addition of a GTTTCTT sequence at the 5'-prime end that consistently results in the addition of a single adenine nucleotide was reported (Brownstein et al., 1996) , thereby eliminating misinterpretation of allele pro®les. One of the possible misinterpretations of microsatellite instability might also be random nontemplated addition of adenine by the Taq-polymerase. According to this principle, we modi®ed the MSH6-(C)8 reverse primer (Malkhosyan et al., 1996) and performed microsatellite instability analysis of the (C)8 repeat of MSH6 in tumours (colon, rectum, ovarian, endometrial, urothelial) of MLH1, MSH2 and MSH6 germline mutation carriers. Subsequently, PCR products were sequenced for the identi®cation of changes in the (C)8 repeat sequence.
Using the modi®ed MSH6-(C)8 reverse primer, we found a markedly lower frequency of instability of the (C)8 repeat of MSH6 in tumours from MLH1, MSH2 or MSH6 germline mutation carriers compared to the frequency observed by using the standard MSH6-(C)8 reverse primer (Table 1) . Instability of respectively 6, 13 and 40% was found in tumours from MLH1, MSH2 and MSH6 germline mutation carriers compared to 56, 50 and 86% using the standard MSH6-(C)8 reverse primer in the same tumours. Subsequently DNA sequencing analysis showed in 45% of PCR products generated by PCR ampli®cation using the standard MSH6-(C)8 reverse primer no sequence change in the (C)8 repeat (one example is shown in Figure 1a ). In the PCR products generated by using the modi®ed MSH6-(C)8 reverse primer an unequivocally sequence change in the (C)8 repeat was identi®ed (Figure 1b) . In total, in 10 tumours a single base pair deletion was found (two tumours from MSH2 and eight tumours from MSH6 mutation carriers). In three tumours a single base pair insertion was found using the modi®ed (C)8-MSH6 reverse primer (one tumour from MLH1 and two tumours from MSH6 mutation carriers, Figure 1c) . No sequence changes of two or more base pairs were identi®ed.
Furthermore, using the improved detection of instability of the (C)8 repeat of MSH6, the frequency of instability of the (C)8 repeat in tumours from MLH1 and MSH2 germline mutation carriers was signi®cant lower (P=0.02) compared to tumours from MSH6 germline mutation carriers, 6 and 13 versus 40%, respectively. The signi®cant higher frequency of instability of the (C)8 repeat of MSH6 might indicate: (i) a possible selective pressure which might contribute to biallelic inactivation of MSH6 by instability of the (C)8 repeat in tumours (40%) from MSH6 mutation an ABI PRISM 310 Genetic Analyzer (PE Biosystems Inc., Foster City, USA) for 20 min with runpro®le GS STR POP4 (1.0 ml) C and analysed with GeneScan 2.1.1. (normal DNA, blue peaks; tumour DNA, green peaks). Direct cycle sequencing of the PCR products were performed using the BigDye-Terminator chemistry recommended by the manufacturer (PE Biosystems Inc., Foster City, USA), containing 3.2 pmol MSH6-(C)8 reverse primer; 5'-TTT CCT GCT CCT CTT CCT CA-3' for 968C for 30 s, 558C for 15 s, 708C for 4 min in a GeneAmp 9700 thermocycler (PE Biostystems Inc., Foster City, USA). Sequencing reactions were run on an ABI PRISM 310 Genetic Analyzer (PE Biosystems Inc., Foster City, USA) for 36 min using runpro®le BigDye Terminator RAPID sequencing E and analysed with Sequencing Analysis 3.3. (a) Microsatellite analysis of the (C)8 repeat showing misinterpretation of instability (false positive) using the standard MSH6-(C)8 reverse primer. Using the standard MSH6-(C)8 reverse primer two peaks representing two PCR products, one PCR product from normal DNA and one PCR product from tumour DNA with a dierence of one base pair are detected. No dierence in the electrophoresis mobility was observed using the modi®ed MSH6-(C)8 reverse primer (both PCR products from normal-and tumour DNA migrate at the same position). Sequence analysis of PCR products generated using the standard or modi®ed MSH6-(C)8 reverse primer from normal-and tumour DNA do not show any sequence change in the (C)8 repeat. (b) Microsatellite analysis of the (C)8 repeat in a tumour from a MSH6 germline mutation carrier with a germline mutation in the (C)8 repeat (nucleotide change: 1085 delC, leading to a frameshift and a stop codon at nucleotide position 1092), showing instability of a one base pair deletion in the (C)8 repeat in tumour DNA. Using the standard MSH6-(C)8 reverse primer multiple PCR products are detected. Using the modi®ed MSH6-(C)8 reverse primer two distinct PCR products from normal DNA are detected, representing one germline mutated allele (mut) and one wild type allele (wt). In tumour DNA only one PCR product is detected, at the position of the germline mutated allele. Sequence analysis of PCR products from normal DNA con®rmed the presence of a (heterozygous) germline deletion C mutation ((C)8/(C)7 repeat, arrow). In PCR products from tumour DNA a (homozygous) deletion C mutation was identi®ed ((C)7 repeat). This observation indicates a somatic deletion C mutation of the wild type allele. (c) Microsatellite analysis of the (C)8 repeat showing instability in tumour DNA due to a one base pair insertion in the (C)8 repeat of MSH6. Using the standard MSH6-(C)8 reverse primer two PCR products from both normal and tumour DNA are detected. Using the modi®ed MSH6-(C)8 reverse primer one single PCR product from normal DNA is detected. In tumour DNA two PCR products are identi®ed, one of the wt allele (wt) and one of the somatic mutated allele as a one base pair insertion (mut). Sequence analysis of PCR products from tumour DNA con®rmed a (heterozygous) insertion C mutation ((C)8/(C)9 repeat, arrow) Akiyama et al. (1997) and Miyaki et al. (1997) showed somatic frameshift mutations in the (C)8 repeat of MSH6 in tumours from MSH6 mutation carriers. In both studies it was claimed that somatic mutations in the (C)8 repeat of MSH6 presumably aect the wild-type allele, indicating inactivation of both MSH6 alleles according to the two-hit inactivation model of Knudson et al. (1971) and leading to an enhanced MSI in tumours. In this study we observed the inactivation of the wild-type MSH6 allele in two tumours from two MSH6 germline carriers from one kindred with a germline mutation (one basepair deletion) in the (C)8 repeat of MSH6 (Figure 1b) . In total, only in three of 32 (10%) tumours from MLH1 or MSH2 germline mutation carriers instability of the (C)8 repeat of MSH6 was found using the modi®ed MSH6-(C)8 reverse primer. In two tumours from two kindreds with a germline mutation in intron 9 (splice acceptor site of exon 10) of MSH2 a single base pair deletion was identi®ed. In one tumour from a germline mutation carrier with a missense mutation in MLH1 a single base pair insertion in the (C)8 repeat sequence was found. It has not been de®nitely proven whether both mutations are true pathogenic mutations or rather sequence variants.
In conclusion, our data show that the detection of instability of the (C)8 repeat of MSH6 might be biased (`false positives'). Using an improved detection of instability of the (C)8 repeat of MSH6 a markedly lower frequency of microsatellite instability of the (C)8 repeat in tumours of MSH6 germline mutation carriers was found. These data might have similar implications for the detection of instability in other mononucleotide repeats. For example, in a recent publication only a part of PCR products of mononucleotide repeats of MSH3, MSH6, TGFbRII, BAX, IGFRII and TCF4, showing a electrophoresis mobility shift were sequenced to con®rm somatic frameshift mutations (Planck et al., 2000) . We recommend to validate these analysis in view of the results described in this report. Systematic sequencing of PCR products as was performed for the (A)10 repeat of TGFbRII in colorectal tumors in previous studies might reveal similar results Akiyama et al., 1996; Togo et al., 1996; Markowitz et al., 1995) .
